The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Susana Ortiz‐Urda|Molecular Cancer|2024Cited by 14
Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependenciesValentin Feichtenschlager, Susana Ortiz-Urda|Communications Medicine|2025Cited by 2
The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Susana Ortiz‐Urda|Research Square|2023Cited by 1